What is the catalog number for Kv4.3/KCND3 Rabbit Polyclonal Antibody?

The catalog number for Kv4.3/KCND3 Rabbit Polyclonal Antibody is orb215983.

What sizes are available for Kv4.3/KCND3 Rabbit Polyclonal Antibody?

Kv4.3/KCND3 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Kv4.3/KCND3 Rabbit Polyclonal Antibody in stock?

Kv4.3/KCND3 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Kv4.3/KCND3 Rabbit Polyclonal Antibody

Anti-Kv4.3/KCND3 Antibody. Tested in WB applications. This antibody reacts with Human, Mouse.

Product Specifications

Product Name Alternative

Potassium voltage-gated channel subfamily D member 3; Voltage-gated potassium channel subunit Kv4.3; KCND3

UniProt

Q9UK17

Reactivity

Human, Mouse

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

E.coli-derived human Kv4.3 recombinant protein (Position: M1-H177) . Human Kv4.3 shares 100% and 99% amino acid (aa) sequences identity with mouse and rat Kv4.3, respectively.

Target

A-type voltage-gated potassium channel KCND3

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cancer Biology, Cardiovascular Research, Cell Biology, Immunology & Inflammation, Metabolism Research, Neuroscience, Signal Transduction

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Mouse, Human

Form

Lyophilized

Molecular Weight

73 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9 mg NaCl, 0.2 mg Na2HPO4, and 0.05 mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.